Contact Us |
with Medicare will be eligible for claims coverage from CMS if they participate
in this study. View clinical, billing, and reimbursement information
Participating Transplant Center are Required to:
This study uses the existing research observational database of the CIBMTR to
collect data requested by CMS as part of its payment policy. Participants who
wish to receive coverage from CMS must sign the existing IRB approved CMS consent for the study. Additional
protocol or consent forms are not required for this study.
The Research Database protocol, CMS consent form and CIBMTR/NMDP IRB approvals, can be found on
Database and Protocol and Consent Forms page.
has determined allogeneic HCT for MDS to be reasonable and necessary ONLY if
provided in a Medicare approved clinical study under Coverage with Evidence
learn more about specific codes to use for this clinical trial, view
Claims Processing Manual - transplant section 90.3 or
a Medicare Matters